Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Here's Why Wall Street Is Super Bullish on Moderna Stock
03:45pm, Thursday, 15'th Sep 2022 The Motley Fool
Wall Street thinks the bear market has pushed this top biotech stock down too far.
Moderna And Covid-19 Stocks: Market-Maker Stock Price Range Forecasts
02:06pm, Thursday, 15'th Sep 2022
The World Health Organization list of Vaccine makers, rapid antigen test manufacturers, and therapeutics were bundled together as a participants group for coming price-range-forecast comparison. The f
Here's Why Wall Street Is Super Bullish on Moderna Stock
11:45am, Thursday, 15'th Sep 2022
Wall Street thinks the bear market has pushed this top biotech stock down too far.
If You've Got $5,000, Buying These 5 Top Stocks Right Now Would Be a Genius Move
11:16am, Thursday, 15'th Sep 2022 The Motley Fool
These stocks have what it takes to deliver lasting gains down the road.
Nasdaq Closes Higher But CNN Fear & Greed Index Remains In 'Fear' Zone
10:19am, Thursday, 15'th Sep 2022 Benzinga
The CNN Money Fear and Greed index remained in the "fear" zone after the U.S. stocks closed slightly higher in choppy trading on Wednesday.
The modest gains followed a sharp plunge on Tuesday, when th
If You've Got $5,000, Buying These 5 Top Stocks Right Now Would Be a Genius Move
07:16am, Thursday, 15'th Sep 2022
These stocks have what it takes to deliver lasting gains down the road.
Why Moderna Stock Is on Fire Today
05:29pm, Wednesday, 14'th Sep 2022 The Motley Fool
A possible vaccine supply deal with China has investors piling into the biotech's shares.
Argus Research Maintains Buy Rating for Moderna: Here's What You Need To Know
04:15pm, Wednesday, 14'th Sep 2022 Benzinga
Argus Research has decided to maintain its Buy rating of Moderna (NASDAQ:MRNA) and lower its price target from $180.00 to $150.00.
Shares of Moderna are trading up 7.03% over the last 24 hours, at $14
Why Moderna Stock Is on Fire Today
01:29pm, Wednesday, 14'th Sep 2022
A possible vaccine supply deal with China has investors piling into the biotech's shares.
Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More…
12:24pm, Wednesday, 14'th Sep 2022 Benzinga
Reuters
Google And Facebook Parent Fined Millions Of Dollars By South Korea Over Privacy Law Violations
South Korea has imposed fines to the tune of millions of dollars on Alphabet Inc's (NASDAQ:
What's Moderna's Next Billion-Dollar Market? The Answer May Surprise You.
10:30am, Wednesday, 14'th Sep 2022 The Motley Fool
Moderna wants to conquer a virus we all know pretty well.
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
10:20am, Wednesday, 14'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for RYH
What's Moderna's Next Billion-Dollar Market? The Answer May Surprise You.
06:30am, Wednesday, 14'th Sep 2022
Moderna wants to conquer a virus we all know pretty well.
U.S. known COVID cases hold at lowest level since May, but infections are rising again in New York
06:50pm, Tuesday, 13'th Sep 2022 MarketWatch
U.S. known cases of COVID are continuing to ease and now stand at their lowest level since early May, although the numbers need to be viewed gently, given the number of people testing at home, where t
Pfizer (PFE), BioNTech Omicron BA.4, BA.5 Boosters Get CHMP Nod
04:05pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Pfizer (PFE) and BioNTech (BNTX) get a positive recommendation from CHMP for Omicron BA.4 and BA.5-adapted bivalent vaccines.
